Skip to NavigationSkip to content

News

Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of cancer, paying $300 million...
Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are looking good...
Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology...
The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according to multinational law firm...
French pharmaceutical giant Sanofi will pay US biotech Regeneron $582 million, as part of a restructuring of an earlier deal between the two firms.
Aevi Genomic Medicine has seen its share value plummet by 75% following the failure of its experimental attention deficit hyperactivity disorder (...
It’s good news for both asthma patients and AstraZeneca after UK drug watchdog NICE saw fit to recommend the drugmaker’s Fasenra (benralizumab)...
The MHRA has called on pharmacies across the UK to recall blood pressure products containing irbesartan due to possible contamination with cancer-...
Takeda has revealed that it is set to bolster its novel immuno-oncology portfolio with three new research collaborations. The Japanese...
Bristol-Myers Squibb has announced its intention to acquire fellow drugmaker Celgene as part of an agreement which, valued at approximately $74...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches